Belgian Molecular Profiling program of metastatic cancer for clinical decision and treatment assignment Last updated: 2024-03-12 10:53
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria Last updated: 2023-02-03 03:36
Integrated Exposomic Analysis of Myocardial Infarction Risk: A Belgian Population Based Study Last updated: 2022-10-18 17:23